Addex Therapeutics Ltd.
ADXN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574232
No open-market purchases or sales by Addex Therapeutics Ltd. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $274 in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Addex Therapeutics Ltd. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 4 | 4 | 0 |
| Shares | 508.7K | 508.9K | +285 (+0.1%) |
| Value | $20.4M | $4.59M | −$15.8M (−77.5%) |
New holders (0)
Institutions that held Addex Therapeutics Ltd. at the end of Q3 2021 but not at the end of Q2 2021.
None.
Sold out (0)
Institutions that held Addex Therapeutics Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.
None.